CHILD
MCID: CHL079
MIFTS: 27

Children's Interstitial Lung Disease (CHILD)

Categories: Rare diseases, Respiratory diseases

Aliases & Classifications for Children's Interstitial Lung Disease

MalaCards integrated aliases for Children's Interstitial Lung Disease:

Name: Children's Interstitial Lung Disease 53
Primary Interstitial Lung Disease Specific to Childhood 53 59
Primary Ild Specific to Childhood 53 59
Child 53

Classifications:

Orphanet: 59  
Rare respiratory diseases


External Ids:

Orphanet 59 ORPHA264665

Summaries for Children's Interstitial Lung Disease

NIH Rare Diseases : 53 Children's interstitial and diffuse lung disease (chILD) is not a single condition, but a group of rare lung diseases found in infants, children and adolescents that can range from mild to severe. All types of chILD decrease a child's ability to supply oxygen to their body. These diseases make it difficult for the lungs to exchange oxygen and carbon dioxide and can cause fluid and other materials to collect in the lungs. Early diagnosis and treatment is important for any type of chILD. See the Children's Interstitial Lung Disease Foundation to see a list of different ILDs and to find more information about diagnosis, treatment and help finding a specialist.

MalaCards based summary : Children's Interstitial Lung Disease, also known as primary interstitial lung disease specific to childhood, is related to primary interstitial lung disease specific to childhood due to alveolar structure disorder and primary interstitial lung disease specific to childhood due to alveolar vascular disorder. The drugs Nitrazepam and Lamotrigine have been mentioned in the context of this disorder. Affiliated tissues include testes, liver and brain.

Related Diseases for Children's Interstitial Lung Disease

Graphical network of the top 20 diseases related to Children's Interstitial Lung Disease:



Diseases related to Children's Interstitial Lung Disease

Symptoms & Phenotypes for Children's Interstitial Lung Disease

Drugs & Therapeutics for Children's Interstitial Lung Disease

Drugs for Children's Interstitial Lung Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1264)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nitrazepam Approved Phase 4 146-22-5 4506
2
Lamotrigine Approved, Investigational Phase 4 84057-84-1 3878
3
Ferrous succinate Approved Phase 4 10030-90-7
4
Vancomycin Approved Phase 4 1404-90-6 441141 14969
5
Imipenem Approved Phase 4 74431-23-5, 64221-86-9 104838
6
Phenytoin Approved, Vet_approved Phase 4 57-41-0 1775
7
Levodopa Approved Phase 4 59-92-7 6047
8
Reboxetine Approved, Experimental Phase 4 98769-81-4, 71620-89-8 123628 65856
9
acetic acid Approved Phase 4 64-19-7 176
10
Rufinamide Approved Phase 4 106308-44-5 129228
11
Clonazepam Approved, Illicit Phase 4 1622-61-3 2802
12
Stiripentol Approved Phase 4 49763-96-4
13
Clobazam Approved, Illicit Phase 4 22316-47-8 2789
14
Zonisamide Approved, Investigational Phase 4 68291-97-4 5734
15
Ethosuximide Approved Phase 4 77-67-8 3291
16
Cefazolin Approved Phase 4 25953-19-9 656510 33255
17
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
18
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
19
Racepinephrine Approved Phase 4 329-65-7 838
20
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 5754
21
Hydrocortisone acetate Approved, Vet_approved Phase 4 50-03-3
22
Emtricitabine Approved, Investigational Phase 4 143491-57-0 60877
23
Albendazole Approved, Vet_approved Phase 4 54965-21-8 2082
24
Caspofungin Approved Phase 4 179463-17-3, 162808-62-0 468682 2826718
25 Ethiodized oil Approved, Investigational Phase 4 8008-53-5
26
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
27
Azelastine Approved Phase 4 58581-89-8 2267
28
Calcium carbonate Approved, Investigational Phase 4 471-34-1
29
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
30
Ritonavir Approved, Investigational Phase 4 155213-67-5 392622
31
Simvastatin Approved Phase 4 79902-63-9 54454
32
Erythromycin Approved, Investigational, Vet_approved Phase 4 114-07-8 441411 12560
33
Ferrous fumarate Approved Phase 4 141-01-5
34
Methylcobalamin Approved, Experimental, Investigational Phase 4 13422-55-4
35
Hydroxocobalamin Approved Phase 4 13422-51-0 11953898 15589840
36
Zinc Approved, Investigational Phase 4 7440-66-6 32051
37
Iodine Approved, Investigational Phase 4 7553-56-2 807
38
Cycloserine Approved Phase 4 68-41-7 6234 401
39
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
40
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
41
Ketoprofen Approved, Vet_approved Phase 4 22071-15-4 3825
42
Riluzole Approved, Investigational Phase 4 1744-22-5 5070
43
Lumefantrine Approved Phase 4 82186-77-4 6437380
44
Selenium Approved, Investigational, Vet_approved Phase 4 7782-49-2
45
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
46
Nelfinavir Approved Phase 4 159989-64-7 64143
47
Loratadine Approved, Investigational Phase 4 79794-75-5 3957
48
Valproic acid Approved, Investigational Phase 4 99-66-1 3121
49
Salicylic acid Approved, Investigational, Vet_approved Phase 4 69-72-7 338
50
Heparin Approved, Investigational Phase 4 9005-49-6 46507594 772

Interventional clinical trials:

(show top 50) (show all 8908)
# Name Status NCT ID Phase Drugs
1 Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients Unknown status NCT02327676 Phase 4 Emtricitabine
2 Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars Unknown status NCT02286648 Phase 4 Formocresol;Mineral Trioxide Aggregate
3 Children's Healthy Living Program for Remote Underserved Minority Populations in the Pacific Region Unknown status NCT01881373 Phase 4
4 A Two-site Randomised Trial of an Additional Measles Vaccine at 4 Months of Age to Reduce Child Mortality in Rural Areas of Burkina Faso and Guinea-Bissau Unknown status NCT01644721 Phase 4
5 A Two-site Randomised Trial of an Additional Measles Vaccine at 4 Months of Age to Reduce Child Mortality in Rural Areas of Burkina Faso and Guinea-Bissau Unknown status NCT01668745 Phase 4
6 Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver Disease (BRAVE): Korean Nation-wide Multicenter Retrospective and Prospective Observational Cohort Study Unknown status NCT02837302 Phase 4 Livact
7 A Randomised Trial of an Additional Measles Vaccine at 4 Months of Age to Reduce Child Mortality and to Explore the Role of Maternal Measles Antibodies for the Beneficial Non-specific Effects of Measles Vaccine Unknown status NCT01486355 Phase 4
8 The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy Unknown status NCT00647322 Phase 4
9 Child With Severe Aplastic Anemia (SAA) Therapy: the Injection of Umbilical Cord Derived Mesenchymal Stem Cells. Unknown status NCT02218437 Phase 4 MSC+ATG
10 Antidepressant Treatments During Pregnancy and Lactation: Prediction of Drug Exposure Through Breastfeeding and Evaluation of Drug Effect on the Neonatal Adaptation and the Development of the Young Child Unknown status NCT01796132 Phase 4 SSRI/SNRI
11 Randomized, Controlled Study of Iron Supplementation of Infants With Birth Weights 2000-2500 g Unknown status NCT00558454 Phase 4 Iron
12 Cohort Prospective Study of Children With Head and Neck Cystic Malformation Who Are Treated With Intracystic OK432 Unknown status NCT01699347 Phase 4 Intracystic injection of OK432 under US guiding
13 Effect of Dexamethasone or Clonidine When Given as Adjuncts to Ropivacaine for Caudal Analgesia on Duration of Analgesia Compared to Placebo in Children Unknown status NCT02773602 Phase 4 Dexamethasone;Clonidine;Normal Saline
14 Clinical Study on the Effects of Propofol for Treatment on Emergence Agitation After Sevoflurane Anesthesia in Pediatric Strabismus Surgery Unknown status NCT02738814 Phase 4 propofol
15 Comparing Rapid Bronchodilatory Effect of Formoterol and Salbutamol in Children Between 5-15 Years With Mild to Moderate Acute Exacerbation of Asthma- A Double Blind Randomized Controlled Trial Unknown status NCT00900874 Phase 4 salbutamol;Formoterol
16 Efficacy and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for the Treatment of Uncomplicated Malaria in Guinea-Bissau. Unknown status NCT01704508 Phase 4 Artemether-lumefantrine;Dihydroartemisinin-piperaquine
17 The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau Unknown status NCT00137566 Phase 4 acetaminophen (paracetamol)
18 Prospective Comparative Study of the Efficacy of Common Antipyretic Treatments in Febrile Children Unknown status NCT02294071 Phase 4 Ibuprofen;Acetaminophen
19 Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD Unknown status NCT00318981 Phase 4 Concerta
20 Use of Silicone Gel to Improve Retroauricular Scar in Microtia Patients Unknown status NCT02518035 Phase 4 Silicone Gel
21 Effect of Vitamin D Supplementation in Young Children With Acute Lower Respiratory Tract Infection at Dr George Mukhari Academic Hospital, Pretoria, South Africa Unknown status NCT02054182 Phase 4 Vitamin D
22 Different Doses of Anti-thymocyte Globin With 2.5 or 3.75mg/kg to Treat Child Severe Aplastic Anemia Unknown status NCT01997372 Phase 4 ATG
23 Efficacy of Combined Oral L-Ornithine-L-Aspartate and Oral Lactulose in Patients With Hepatic Encephalopathy Unknown status NCT00740142 Phase 4 L-ornithine-L-aspartate and lactulose;placebo and lactulose
24 Entecavir for Patients With Decompensated HBV-Related Cirrhosis:a Prospective Randomized Controlled Trial Unknown status NCT00663182 Phase 4 Entecavir
25 Evaluation of Family Intervention Program for the Treatment of Overweight or Obese Children (Nereu Program): Randomized Clinical Trial Unknown status NCT01878994 Phase 4
26 A Phase IV, Single-site, Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum Unknown status NCT02199925 Phase 4 Gammaplex 5%
27 Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis- An Investigator-initiated, Phase IV, Randomised Double-blind Multi-centre Trial of the Benefits and Harms of Aripiprazole Versus Quetiapine in Children and Adolescents With Psychosis Unknown status NCT01119014 Phase 4 Aripiprazole;Quetiapine
28 The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age Unknown status NCT01306006 Phase 4
29 A 12-Month Open Label Safety Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR®) in Children Ages 4-5 Years Diagnosed With Attention-Deficit/Hyperactivity Disorder (ADHD) Unknown status NCT02677519 Phase 4 Aptensio XR
30 Randomized,Double-blind, Placebo Controlled Clinical Trial to Evaluate the Efficacy of the Phytotherapic Compound "Bromelin" on Acute Irritative Cough Unknown status NCT01356693 Phase 4 Bromelin;Placebo
31 Propofol and Fentanyl Versus Midazolam and Fentanyl for Sedation During Diagnostic or Therapeutic Gastrointestinal Endoscopy in Cirrhotic Patients Unknown status NCT00906139 Phase 4 Propofol;Midazolam;Fentanyl
32 Comparison of the Ahmed Glaucoma Valve FP7 and FP8 in Pediatric Glaucoma: a Randomized Clinical Trial. Unknown status NCT01494974 Phase 4
33 Multicenter Study Evaluating the Efficacy of Dicopeg Junior in Comparison With Lactulose for the Treatment of Functional Constipation in Children Aged 6 Months to 6 Years. A Prospective, Randomized Study. Unknown status NCT03177434 Phase 4 polyethylene glycols (PEG) 3350;Lactulose Oral Product
34 The Effect and Reliability of Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders Unknown status NCT03122158 Phase 4 Escitalopram
35 Tenofovir Disoproxil Fumarate in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus in Highly Viremic Mothers Unknown status NCT01488526 Phase 4 TDF treatment
36 Interest of Placental Alpha-microglobulin-1 Detection Test to Assess Risk of Premature Delivery in Reunion Island Unknown status NCT02904070 Phase 4
37 Healthy Opportunities for Physical Activity and Nutrition (HOP'N) After-School Project Unknown status NCT01015599 Phase 4
38 Effect of Perineural Dexmedetomidine on the ED50 Ropivacaine for Brachial Plexus Blocks in Pediatric Patients: a Randomized Trial Unknown status NCT02781246 Phase 4 perineural dexmedetomidine
39 Effects of a Probiotic Supplement on Symptoms of ADHD and Anxiety in Children Unknown status NCT02545634 Phase 4
40 Effect of Vitamin d Supplementation on the Control of Persistent Asthma in Children at Dr George Mukhari Academic Hospital, Pretoria, South Africa Unknown status NCT02053402 Phase 4 Vitamin D
41 Phase 4 Study of Sarpogrelate That Prevent Contrast-induced Nephropathy Unknown status NCT01165567 Phase 4 sarpogrelate
42 Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study Unknown status NCT01361373 Phase 4 L- DOPA;placebo
43 Randomized and Controlled Study of Endoscopic Ligation, Nadolol and Isosorbide Mononitrate vs Endoscopic Ligation and Nadolol Alone, or Associated With Isosorbide Mononitrate or Prazosin, Depending of the Hemodinamyc Response Unknown status NCT00563602 Phase 4
44 Phase 3 Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study Unknown status NCT00426946 Phase 4 Reboxetine
45 Immunogenicity Of A Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, And 18) L1 Virus-Like Particle Vaccine In Male And Female Adolescent Transplant Recipients. Unknown status NCT01101750 Phase 4
46 A Multicenter Study to Evaluate the Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency Unknown status NCT02594904 Phase 4 Yinzhihuang Oral Liquid
47 Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis Unknown status NCT01438437 Phase 4
48 Cymbalta for Depression as a Complication of Bereavement Unknown status NCT00658931 Phase 4 Drug treatment with Cymbalta
49 Oxytocin-based Pharmacotherapy for Autism Spectrum Disorders: Investigating the Neural and Behavioral Effects of a Promising Intervention Approach Unknown status NCT02940574 Phase 4 Syntocinon (Oxytocin)
50 Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related Hepatocellular Carcinoma With Low HBV DNA Replication: Effectiveness and Safety. A Prospective and Randomized Clinical Trial Unknown status NCT01894269 Phase 4 Lamivudine 100mg once daily; or Entecavir 0.5mg once daily.

Search NIH Clinical Center for Children's Interstitial Lung Disease

Genetic Tests for Children's Interstitial Lung Disease

Anatomical Context for Children's Interstitial Lung Disease

MalaCards organs/tissues related to Children's Interstitial Lung Disease:

41
Testes, Liver, Brain, Lung, Bone, Heart, Breast

Publications for Children's Interstitial Lung Disease

Articles related to Children's Interstitial Lung Disease:

(show all 29)
# Title Authors PMID Year
1
Patient education for children with interstitial lung diseases and their caregivers: A pilot study. 38
30709570 2019
2
Long-Term Lung Function and Exercise Capacity in Postinfectious chILD. 38
31032143 2019
3
The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration. 38
30523205 2018
4
ChILD - Children's interstitial lung disease. 38
30519307 2018
5
Development and validation of a health-related quality of life questionnaire for pediatric patients with interstitial lung disease. 38
29687642 2018
6
Diagnostic accuracy and therapeutic relevance of thoracoscopic lung biopsies in children. 38
29578653 2018
7
International management platform for children's interstitial lung disease (chILD-EU). 38
29056600 2018
8
Increased Risk of Interstitial Lung Disease in Children with a Single R288K Variant of ABCA3. 38
26928390 2016
9
Update on Diffuse Lung Disease in Children. 38
26502226 2016
10
Transforming growth factor-beta 1 in humidifier disinfectant-associated children's interstitial lung disease. 38
26111363 2016
11
Humidifier disinfectant-associated children's interstitial lung disease: Computed tomographic features, histopathologic correlation and comparison between survivors and non-survivors. 38
25991482 2016
12
[Modern Views on Children's Interstitial Lung Disease]. 38
26234096 2015
13
Humidifier disinfectant-associated children's interstitial lung disease. 38
24199596 2014
14
[Neuroendocrine cell hyperplasia of infancy--case study]. 38
24964239 2014
15
Diffuse lung disease in infancy and childhood: expanding the chILD classification. 38
24117670 2013
16
Interstitial lung disease in children. 38
23973003 2013
17
Inhalation toxicity of humidifier disinfectants as a risk factor of children's interstitial lung disease in Korea: a case-control study. 38
23755124 2013
18
New coding in the International Classification of Diseases, Ninth Revision, for children's interstitial lung disease. 38
22948581 2012
19
Paediatric interstitial lung disease: classification and definitions. 38
22018036 2011
20
Familial neuroendocrine cell hyperplasia of infancy. 38
20623780 2010
21
ChILD Family Education. 38
22332033 2010
22
Infants and Young Children with Children's Interstitial Lung Disease. 38
22332029 2010
23
Genetic Basis of Children's Interstitial Lung Disease. 38
22087432 2010
24
Round Table Discussion: Children's Interstitial Lung Disease. 38
22332034 2010
25
Expanding Our Understanding of Children's Interstitial Lung Disease. 38
22332027 2010
26
Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism. 38
19237389 2009
27
Evaluating infants and children with interstitial lung disease. 38
17562503 2007
28
How to evaluate and treat children's interstitial lung disease. 38
16798580 2006
29
Surfactant dysfunction mutations in children's interstitial lung disease and beyond. 38
16216835 2005

Variations for Children's Interstitial Lung Disease

Expression for Children's Interstitial Lung Disease

Search GEO for disease gene expression data for Children's Interstitial Lung Disease.

Pathways for Children's Interstitial Lung Disease

GO Terms for Children's Interstitial Lung Disease

Sources for Children's Interstitial Lung Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....